Prostate cancer is one of the most common cancers among men worldwide. The STAMPEDE trial provides valuable data on how different systemic therapies can improve survival rates and quality of life for patients with advanced or metastatic prostate cancer. By testing multiple treatment arms simultaneously, the trial accelerates the identification of effective therapies.
